These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 10173086)

  • 1. Dual diagnosis care for severe and persistent disorders. A comparison of three methods.
    Jerrell JM; Ridgely MS
    Behav Healthc Tomorrow; 1997 Jun; 6(3):26-33. PubMed ID: 10173086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance abuse with mental disorders: specialized public systems and integrated care.
    Burnam MA; Watkins KE
    Health Aff (Millwood); 2006; 25(3):648-58. PubMed ID: 16684728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
    Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
    Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in the assessment of specialized treatments for substance abuse among people with severe mental illness.
    Jerrell JM; Ridgely MS
    J Psychoactive Drugs; 1995; 27(4):347-55. PubMed ID: 8788691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders.
    Mangrum LF; Spence RT; Lopez M
    J Subst Abuse Treat; 2006 Jan; 30(1):79-84. PubMed ID: 16377455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment for dual diagnosis patients in the psychiatric and substance abuse systems.
    Timko C; Dixon K; Moos RH
    Ment Health Serv Res; 2005 Dec; 7(4):229-42. PubMed ID: 16320106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual diagnosis: approaches to the treatment of people with dual mental health and drug abuse problems.
    Manley D
    Ment Health Care; 1998 Feb; 1(6):190-2. PubMed ID: 9791410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of managed behavorial healthcare on the costs of psychiatric and chemical dependency treatment.
    Geraty R; Bartlett J; Hill E; Lee F; Shusterman A; Waxman A
    Behav Healthc Tomorrow; 1994; 3(2):18-30. PubMed ID: 10172255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mental illness and substance use: an Australian perspective.
    Munro I; Edward KL
    Int J Ment Health Nurs; 2008 Aug; 17(4):255-60. PubMed ID: 18666908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The costs of behavioral health care coverage.
    Sterman P
    Empl Benefits J; 1997 Mar; 22(1):2-10. PubMed ID: 10172938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the cost impact of three dual diagnosis treatment programs.
    Jerrell JM; Hu TW
    Eval Rev; 1996 Apr; 20(2):160-80. PubMed ID: 10182202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral interventions for dual-diagnosis patients.
    Goldsmith RJ; Garlapati V
    Psychiatr Clin North Am; 2004 Dec; 27(4):709-25. PubMed ID: 15550289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mental health and addictions: renewed hope for better care.
    Beal G
    Can J Nurs Res; 2003 Mar; 35(1):89-93. PubMed ID: 12854244
    [No Abstract]   [Full Text] [Related]  

  • 15. Responding to the threat of HIV among persons with mental illness and substance abuse.
    Parry CD; Blank MB; Pithey AL
    Curr Opin Psychiatry; 2007 May; 20(3):235-41. PubMed ID: 17415075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing program capability to provide treatment for co-occurring substance use and mental disorders: organizational characteristics.
    Gotham HJ; Claus RE; Selig K; Homer AL
    J Subst Abuse Treat; 2010 Mar; 38(2):160-9. PubMed ID: 19717273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial interventions for the long-term management of patients with severe mental illness and co-occurring substance use disorder.
    Brunette MF; Mueser KT
    J Clin Psychiatry; 2006; 67 Suppl 7():10-7. PubMed ID: 16961419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two worlds of treatment are converging.
    Enos G
    Behav Healthc Tomorrow; 2002 Jun; 11(3):SR31. PubMed ID: 12085434
    [No Abstract]   [Full Text] [Related]  

  • 19. Views of Australian mental health stakeholders on clients' problematic drug and alcohol use.
    Cleary M; Hunt GE; Matheson S; Walter G
    Drug Alcohol Rev; 2009 Mar; 28(2):122-8. PubMed ID: 19320696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The five Cs of choice. Outcome measures for individuals with severe and persistent mental illness.
    Blankertz L; Cook J; Rogers S; Hughes R
    Behav Healthc Tomorrow; 1997 Aug; 6(4):62-7. PubMed ID: 10169472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.